Hi Stockrock, I'm curious to know if the current cohort continue on to be dosed with the increased dosage each time or do they begin with an entirely new cohort of patients. I suspect it will be a new cohort, but would the current patients continue to be dosed after the trial if stable disease was achieved ?
Just wondering if you may know. [Thanks for your contribution here]
Pete
CHM Price at posting:
29.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)